South African regulators decided Vertex Pharmaceuticals has provided sufficient access to its cystic fibrosis medications, ending a high-profile episode that placed the company on the defensive over the cost of its treatments.
BioNTech SE said on Friday it has been informed by its partner OncoC4 that the U.S. Food and Drug Administration has lifted the partial clinical…
HHMI will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for funds to be awarded in 2027.
Today’s health news in STAT Morning Rounds includes HHMI’s new eligibility criteria, the latest on a California bird flu mystery, and more.
The suspect in the killing of UnitedHealthcare’s CEO appears to cite two prominent critics of the U.S. health care system in his manifesto.
Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes.
With a new administration coming in, advocates worry that the FDA may lose its sense of urgency to ban electrical shock devices.
In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build a genetic medicine.
Enter to compete in this year’s STAT Madness! STAT Madness is a bracket-style tournament to find the best innovations in science and medicine from
Enter to compete in this year’s STAT Madness! STAT Madness is a bracket-style tournament to find the best innovations in science and medicine from
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
